Aerie Pharmaceuticals, Inc.
PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES OR DISORDERS
Last updated:
Abstract:
Provided herein are pharmaceutical compositions, intravitreal implants and particle suspensions comprising a polymer matrix and at lest one therapeutic agent that is released in a substantially linear manner for a particular duration.
Status:
Application
Type:
Utility
Filling date:
5 Mar 2020
Issue date:
1 Oct 2020